144
Participants
Start Date
March 31, 2006
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2007
12.5 mg Proellex
12.5 mg Proellex administered orally daily
25 mg Proellex
25 mg Proellex administered orally daily
Placebo
Administered orally daily
SC Clinical Research Center, Columbia
Miami Research Associates, Women's Health Studies, Miami
Visions Clinical Research, Boynton Beach
Insignia Clinical Research (Tampa Bay Women's Center), Tampa
Alabama Clinical Therapeutics, LLC, Birmingham
Advances in Health Inc., Houston
Obstetrical & Gynecolgical Associates, PA (OGA), Houston
Downtown Women's Health Care, Denver
Women's Health Research, Phoenix
Arizona Wellness Centre for Women, Phoenix
Visions Clinical Research Tuscon, Tuscon
Caring for Women, Las Vegas
Affiliated Clinical Research, Inc., Las Vegas
Medical Centre for Clinical Research, San Diego
Women's Health Care, Inc., San Diego
Women's Clinical Research Centre, Seattle
Repros Therapeutics Inc.
INDUSTRY